LOMGX | Growth Opportunities Fund Class F3 | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Growth Opportunities Fund

Summary

Summary

What is the Growth Opportunities Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of mid-sized U.S. companies.

Fund Basicsas of 09/30/2020

Total Net Assets
$728.70 M
Inception Date
04/05/2017
Dividend Frequency
Annually
Fund Gross Expense Ratio
0.85%
Fund Net Expense Ratio
0.75%
Number of Holdings
99

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 18.28% 28.95% 18.18% 15.11% 13.65% -
Lipper Category Avg. Multi-Cap Growth Funds 24.15% 35.45% 18.66% 16.90% 14.91% -
Russell Midcap® Growth Index 13.92% 23.23% 16.23% 15.53% 14.55% -

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 18.28% 28.95% 18.18% 15.11% 13.65% -
Lipper Category Avg. Multi-Cap Growth Funds 24.15% 35.45% 18.66% 16.90% 14.91% -
Russell Midcap® Growth Index 13.92% 23.23% 16.23% 15.53% 14.55% -

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

RELATED CONTENT

TEN LARGEST HOLDINGS as of 09/30/2020View Portfolio

Holding Assets
RingCentral, Inc. 2.5%
Splunk, Inc. 2.4%
DocuSign Inc 1.9%
O'Reilly Automotive, Inc. 1.9%
Twilio, Inc. 1.9%
Chipotle Mexican Grill, Inc. 1.8%
CoStar Group, Inc. 1.8%
Church & Dwight Co., Inc. 1.7%
Veeva Systems, Inc. 1.7%
Ball Corp. 1.6%

INVESTMENT TEAM

Jeffrey Rabinowitz
Jeffrey Rabinowitz, CFA

Portfolio Manager

21 Years of Industry Experience

Supported By 34 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 18.28% 28.95% 18.18% 15.11% 13.65% -
Lipper Category Avg. Multi-Cap Growth Funds 24.15% 35.45% 18.66% 16.90% 14.91% -
Russell Midcap® Growth Index 13.92% 23.23% 16.23% 15.53% 14.55% -

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 18.28% 28.95% 18.18% 15.11% 13.65% -
Lipper Category Avg. Multi-Cap Growth Funds 24.15% 35.45% 18.66% 16.90% 14.91% -
Russell Midcap® Growth Index 13.92% 23.23% 16.23% 15.53% 14.55% -

Fund Expense Ratio :

Gross 0.85%

Net 0.75%

Year Fund Returns Russell Midcap® Growth Index
2019 37.24% 35.47%
2018 -3.08% -4.75%
2017 23.32% 25.27%
2016 1.42% 7.33%
2015 3.15% -0.20%
2014 6.76% 11.90%
2013 37.82% 35.74%
2012 14.42% 15.81%
2011 -9.62% -1.65%
2010 23.83% 26.38%
2009 46.23% -
2008 -37.98% -
2007 21.67% -
2006 - -
Year Q1 Q2 Q3 Q4 Yearly Returns
2020 -19.35% 31.97% 11.12% - 25.11%
2019 19.98% 6.47% -1.47% 9.02% 37.24%
2018 1.85% 2.58% 7.71% -13.87% -3.08%
2017 7.03% 5.28% 4.32% 4.90% 23.32%
2016 -2.04% 2.58% 2.75% -1.77% 1.42%
2015 7.73% 1.03% -7.72% 2.70% 3.15%
2014 1.32% 3.06% -2.74% 5.11% 6.76%
2013 11.43% 2.81% 11.13% 8.25% 37.82%
2012 17.02% -6.13% 4.31% -0.13% 14.42%
2011 7.85% 0.12% -24.88% 11.42% -9.62%
2010 6.72% -13.66% 15.46% 16.39% 23.83%
2009 -2.25% 17.74% 17.73% 7.92% 46.23%
2008 -12.62% 4.54% -12.20% -22.67% -37.98%
2007 4.11% 6.89% 6.93% 2.24% 21.67%
2006 - - - 6.53% -

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 06/30/2020

  • Our investment philosophy is focused on identifying durable franchises that also exhibit a compelling combination of strong growth prospects and seasoned management teams that are mispriced by the market.
  • While there remains a high degree of uncertainty around the spread of COVID-19, and hence the depth and duration of its impact on the global economy, we believe that governments and health organizations around the world are responding with great urgency to contain this unfortunate situation.  We believe that over the long-term, our economy will return to a more normalized level of activity and people around the world will resume their typical daily activities.
  • We have identified COVID-19 winners that have structurally benefited from the present environment and look to have  sustainable growth. We believe that select companies that have been vulnerable during the global pandemic may be misvalued and over sold.
  • While we cannot predict the depth and duration of the current crisis, we believe that maintaining a disciplined approach and continuing to execute according to our philosophy and process will serve us well.
  • Furthermore, we believe durable franchises will persevere through challenging environments like we are seeing currently.

PORTFOLIO DETAILS as of 09/30/2020

Total Net Assets
$728.70 M
Number of Holdings
99
Weighted Average Market Cap.
24.0 B
P/B Ratio
7.7x
P/E Ratio
36.5x

Contributors & Detractors as of  09/30/2020

Contributors

Holding Contribution
Immunomedics, Inc. 1.1%
Peloton Interactive Inc 0.5%
Docusign Inc 0.4%
Natera, Inc. 0.4%
Charles River Laboratories International, Inc. 0.3%

Detractors

Holding Contribution
Slack Technologies Inc -0.2%
BioMarin Pharmaceutical, Inc. -0.2%
Jack Henry & Associates, Inc. -0.2%
Splunk, Inc. -0.1%
RingCentral, Inc. -0.1%

Attribution Analysis 

Growth Opportunities Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
12/17/2020 12/18/2020 12/18/2020

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
12/17/2019 12/18/2019 $1.3500 - $1.3500 $27.60

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
12/17/2020 12/18/2020

Fees & Expenses

Fees & Expenses

EXPENSE RATIOas of 09/30/2020

Fund Gross Expense Ratio Fund Net Expense Ratio
0.85% 0.75%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Class F3 - The inception date for Class F3 shares is April 4, 2017. The performance quotations for Class F3 are based on the following methods of calculation: (a) for periods prior to June 30, 2015,  a figure is used based on the historical performance of the Fund’s Class I Shares, since inception, restated to reflect all charges and fees applicable to Class F3 shares; (b) for periods prior to April 4, 2017 but after June 30, 2015, performance is based on the historical performance of the Fund’s Class R6 shares, which have an equivalent expense ratio to the Fund’s F3 shares; and (c) for periods after April 4, 2017, actual Class F3 performance is used, which reflects all charges and fees applicable to Class F3 shares.

Class F3 shares are only offered to certain eligible investors. For additional information, see the Fund’s current prospectus.

The Russell Midcap® Growth Index measures the performance of those Russell Midcap companies with higher price-to-book ratios and higher forecasted growth values. The stocks are also members of the Russell 1000 Growth index.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field